# Definium Therapeutics, Inc.: Form 6-K, filed Nov 5, 2021

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 6-K
- Filed: 2021-11-05
- Accepted by EDGAR: Nov 5, 2021, 12:26 ET
- Period: 2021-11-05
- Accession: 0001104659-21-134887
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000110465921134887/tm2132099d1_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000110465921134887/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000110465921134887/tm2132099d1_6k.htm

Filed Nov 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-134887. Last ingested by Listed: Nov 10, 2026, 02:38 ET. No prices; not investment advice.